Schizophrenia Journal
@schizjournal.bsky.social
75 followers 120 following 27 posts
Schizophrenia is a high-quality Springer Nature journal published in partnership with the Schizophrenia Research Society (SIRS) @SIRSGlobal nature.com/npjschz/
Posts Media Videos Starter Packs
schizjournal.bsky.social
A New Chapter for Schizophrenia Journal... 📖
sirsofficial.bsky.social
📖 A New Chapter for Schizophrenia

Thank you to Dr. Robin Emsley for 3.5 years of leadership as Editor. Welcome Dr. Anthony A. Grace, Distinguished Professor and global leader in schizophrenia research, as our new Editor.

Please join us in celebrating this transition!💫
#SIRS #SchizophreniaResearch
schizjournal.bsky.social
New investigation of what lies behind the 17-year reduction in life expectancy gap between #schizophrenia patients and the general population. 2nd-gen antipsychotics and low frequency hospitalization were associated with reduced mortality @sirsofficial.bsky.social bit.ly/4gdulqF
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population? - Schizophrenia
Schizophrenia - What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?
bit.ly
Reposted by Schizophrenia Journal
sirsofficial.bsky.social
📆 September is here! Your SIRS Submission Deadlines are Approaching FAST!

Be Part of the Conversation in Florence, Italy
Submit Your Symposia Proposal Today!

#SIRS2026

LINK: sirs.societyconference.com/v2/#card/sub...
schizjournal.bsky.social
This is one of the circuits which has been previously related to symptom improvements in patients with firstepisode of psychosis.
schizjournal.bsky.social
The authors found that treatment-responsive and treatment-resistant psychosis groups differed in longitudinal changes in connectivity between ventral striatal and temporal cortical regions.
schizjournal.bsky.social
How can smartphone and wearable digital biomarkers inform about risk of developing schizophrenia? Learn more about the use of digital phenotyping in the #AMP_SZ study in this new paper #biomarkers @SIRSGlobal bit.ly/4kxW1qH
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program - Schizophrenia
Schizophrenia - Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
bit.ly
schizjournal.bsky.social
Advances in proteomics & genomics are shedding light on biomarkers linked to schizophrenia risk. The AMP® Schizophrenia study is tracking 2,000+ participants to uncover blood & saliva markers that predict outcomes & reveal underlying biology. #Psychiatry #Biomarkers #AMP_SCZ bit.ly/3IB5Dn6
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations - Schizophrenia
Schizophrenia - Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
bit.ly
schizjournal.bsky.social
Dr Jean Addington discusses the challenges and highlights the most important aspects of the selection and application of clinical assessment and outcome measures in the large multisite AMP®SCZ study investigating CHR go.nature.com/4cHoQ1r @sirsofficial.bsky.social vimeo.com/1040425281
Schizophrenia Interview with Dr. Addington
This is "Schizophrenia Interview with Dr. Addington" by SIRS on Vimeo, the home for high quality videos and the people who love them.
vimeo.com
Reposted by Schizophrenia Journal
ivkreis.bsky.social
Late highlight at #SIRS2025 @sirsofficial.bsky.social well worth staying for: symposium on cognitive impairments in psychosis, with chairs @rob-mccutcheon.bsky.social & Ingrid Melle (pic), and Sherry KW Chan, David Lewis, Richard Keefe - highlighting course, contributors, and ways forward.
schizjournal.bsky.social
• Innovative project management systems
• Advanced electronic data capture and aggregation
• Real-time data processing & de-identification
• Seamless data dissemination via NIMH Data Archive
Transforming how complex, sensitive research gets done. 🧠🔬